Format

Send to

Choose Destination
J Pediatr. 2014 Feb;164(2):383-8. doi: 10.1016/j.jpeds.2013.10.013. Epub 2013 Nov 16.

Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly.

Author information

1
Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: Stacy.Croteau@childrens.harvard.edu.
2
Department of Pathology, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
3
Department of Surgery, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
4
Division of Interventional Radiology, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
5
Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
6
Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, MA; Harvard Medical School, Boston, MA.

Abstract

OBJECTIVE:

To describe the clinical and imaging characteristics of a new lymphatic disorder with a unique histological pattern and poor prognosis.

STUDY DESIGN:

An observational, retrospective study identified and characterized 20 patients with distinct lymphatic histopathology referred to the Vascular Anomalies Center at Boston Children's Hospital between 1995 and 2011.

RESULTS:

The median age at onset was 6.5 years (range, birth to 44 years). Clinical and radiologic findings suggested a generalized process. The most common presentations were respiratory symptoms (50%), hemostatic abnormalities (50%), and an enlarging, palpable mass (35%). All patients had mediastinal involvement; 19 patients developed pericardial (70%) and/or pleural effusions (85%). Extrathoracic disease manifested in bone and spleen and less frequently in abdominal viscera, peritoneum, integument, and extremities. Despite aggressive procedural and medical therapies, the 5-year survival was 51% and the overall survival was 34%. Mean interval between diagnosis and death was 2.75 years (range, 1-6.5 years).

CONCLUSIONS:

We describe a clinicopathologically distinct lymphatic anomaly. We propose the term kaposiform lymphangiomatosis (KLA) because of characteristic clusters or sheets of spindled lymphatic endothelial cells accompanying malformed lymphatic channels. The intrathoracic component is most commonly implicated in morbidity and mortality; however, extrathoracic disease is frequent, indicating that KLA is not restricted to pulmonary lymphatics. The mortality rate of KLA is high despite aggressive multimodal therapy.

KEYWORDS:

GLA; Generalized lymphatic anomaly; KHE; KLA; Kaposiform hemangioendothelioma; Kaposiform lymphangiomatosis; MRI; Magnetic resonance imaging

PMID:
24252784
PMCID:
PMC3946828
DOI:
10.1016/j.jpeds.2013.10.013
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center